Haemonetics Corp
NYSE:HAE

Watchlist Manager
Haemonetics Corp Logo
Haemonetics Corp
NYSE:HAE
Watchlist
Price: 78.1 USD
Market Cap: 3.9B USD
Have any thoughts about
Haemonetics Corp?
Write Note

Haemonetics Corp
Goodwill

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Haemonetics Corp
Goodwill Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Goodwill CAGR 3Y CAGR 5Y CAGR 10Y
Haemonetics Corp
NYSE:HAE
Goodwill
$616.2m
CAGR 3-Years
10%
CAGR 5-Years
24%
CAGR 10-Years
6%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Goodwill
$1.9B
CAGR 3-Years
-21%
CAGR 5-Years
-10%
CAGR 10-Years
-1%
ICU Medical Inc
NASDAQ:ICUI
Goodwill
$1.5B
CAGR 3-Years
256%
CAGR 5-Years
166%
CAGR 10-Years
99%
Align Technology Inc
NASDAQ:ALGN
Goodwill
$471.5m
CAGR 3-Years
3%
CAGR 5-Years
49%
CAGR 10-Years
23%
Lantheus Holdings Inc
NASDAQ:LNTH
Goodwill
$61.2m
CAGR 3-Years
0%
CAGR 5-Years
31%
CAGR 10-Years
15%
Merit Medical Systems Inc
NASDAQ:MMSI
Goodwill
$399.4m
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
8%
No Stocks Found

Haemonetics Corp
Glance View

Market Cap
3.9B USD
Industry
Health Care

In the realm of healthcare, Haemonetics Corp. operates as a pivotal player, bridging the gap between innovation and life-saving technology. Founded in 1971, the company has evolved to become a leader in blood management solutions, riding the wave of advanced medical technology to cater primarily to hospitals and blood collection centers. At its core, Haemonetics specializes in products and software designed to optimize the collection, processing, and surgical use of blood. Among its notable contributions are devices for blood component separation and coagulation management systems, which play a critical role in ensuring that patients around the world receive safe and effective blood therapy. Revenue streams for Haemonetics come from a diverse range of blood management systems and services. Their offerings are not limited to physical products; the company also provides comprehensive software solutions that help institutions maximize efficiencies and improve patient outcomes. With a keen focus on research and development, Haemonetics continuously innovates to meet the stringent demands of the modern healthcare landscape. Their business model thrives on a combination of direct sales, strategic partnerships, and service agreements with hospitals and blood banks, all while maintaining a strong commitment to quality and regulatory compliance. Through its strategic approach, Haemonetics not only fulfills an essential healthcare need but also crafts a sustainable financial pathway by redefining how blood and related products are managed globally.

HAE Intrinsic Value
95.86 USD
Undervaluation 19%
Intrinsic Value
Price

See Also

What is Haemonetics Corp's Goodwill?
Goodwill
616.2m USD

Based on the financial report for Sep 28, 2024, Haemonetics Corp's Goodwill amounts to 616.2m USD.

What is Haemonetics Corp's Goodwill growth rate?
Goodwill CAGR 10Y
6%

Over the last year, the Goodwill growth was 32%. The average annual Goodwill growth rates for Haemonetics Corp have been 10% over the past three years , 24% over the past five years , and 6% over the past ten years .

Back to Top